Which Tools Better Predict Fall Risk in Parkinson's Disease: A Comparative Study of Objective, Self-Reported, and Functional Balance Assessment
Launched by BEZMIALEM VAKIF UNIVERSITY ·
Trial Information
Current as of September 29, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how well different tools can predict the risk of falls in people with Parkinson’s disease (PD). Falls are common in PD and can happen often, so it’s important to find easy and reliable ways to identify who is at higher risk. The study compares three types of balance tests: a machine-based test (called the Biodex Balance System), a questionnaire where patients share how confident they feel about not falling (the Falls Efficacy Scale-International), and a physical balance test done by a therapist (the Mini-Balance Evaluation Systems Test).
People with Parkinson’s disease who are in the early to middle stages of the condition (stages 1 to 3) may be able to join. Participants will keep a diary to track any falls they have, take part in the balance tests mentioned, and answer questions about their confidence in staying steady. This study is currently looking for volunteers of any gender and age within a specified range. Taking part can help researchers find better ways to predict and prevent falls, improving safety and quality of life for people with Parkinson’s.
Gender
ALL
Eligibility criteria
About Bezmialem Vakif University
Bezmialem Vakif University is a prominent academic institution based in Istanbul, Turkey, dedicated to advancing medical research and education. As a clinical trial sponsor, the university leverages its state-of-the-art facilities and a multidisciplinary team of experts to conduct innovative research that aims to improve patient outcomes and enhance therapeutic strategies. Bezmialem Vakif University is committed to adhering to rigorous ethical standards and regulatory guidelines, ensuring the integrity and reliability of its clinical trials while fostering collaboration with global research communities. Through its initiatives, the university seeks to contribute significantly to the field of medicine and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported